$PBFS Cashflow Statement | Understand Stock

$PBFS

$18.18 -$0.06 (0.33%) Close

$PBFS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2023 12 months to Jun 30, 2024	FY2022 12 months to Jun 30, 2023	FY2021 12 months to Jun 30, 2022	FY2020 12 months to Jun 30, 2021
Cash flows from operating activities:
Net income
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
Provision for loan losses
Provision for credit losses
Net accretion on securities
ESOP compensation
(Earnings) loss on bank-owned life insurance
Net gain on sale or write-down of other real estate owned
Proceeds from sale of loans
Net (gain) loss on sale of loans
Loss on sale, disposal or impairment of premises and equipment, net
Goodwill impairment loss
Gain on termination of finance lease, net
Net gain on equity securities
Net (gain) loss on securities available for sale transactions
Net gain on calls of securities held to maturity
Stock-based compensation expense
Deferred tax (benefit) expense
Increase in accrued interest receivable
(Increase) decrease in other assets
(Decrease) increase in other liabilities
Changes in operating leases

Net cash provided by operating activities
Cash flows from investing activities:
Proceeds from maturities, paydowns and calls of securities available for sale
Proceeds from sales of securities available for sale
Purchases of securities available for sale
Proceeds from maturities and paydowns of securities held to maturity
Purchases of securities held to maturity
Proceeds from sales of equity securities
Net purchases of FHLBNY stock
Net (purchases) redemptions of FHLBNY stock
Net purchases of FHLBNY and FRBNY stock
Net increase in loans receivable
Purchases of premises and equipment
Proceeds from the sale of premises and equipment
Proceeds from bank-owned life insurance death benefit
Proceeds from sale of other real estate owned
Cash paid for acquisitions
Net cash used in investing activities

Cash flows from financing activities:
Net increase (decrease) in deposits
Net increase (decrease) in mortgagors' escrow deposits
Proceeds from exercise of stock options
Proceeds from FHLBNY borrowings, net
Payments on acquisition contingent consideration
Repurchase of common stock
Purchase of employee restricted shares to fund statutory tax withholding
Repayment of finance lease liability
Net cash provided by (used in) financing activities
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental disclosure of cash flow information:
Cash paid during the period for:
Interest
Income taxes
Non-cash investing and financing activity:
Loans transferred to other real estate owned
Acquisition contingent consideration payable
Right of use assets obtained in exchange for new finance lease liabilities
Right of use assets obtained in exchange for new operating lease liabilities
Right of use assets
Lease liabilities

Comments